In a strategic move to strengthen its presence in Europe, Indegene, a digital-first life sciences commercialization company, has announced the launch of a new center in London. This expansion is part of the company’s broader growth strategy, reinforcing its commitment to supporting life sciences organizations in the region with advanced commercialization solutions and AI-driven innovations.

The newly established center in London will serve as a key hub for Indegene’s Europe-based clients, enabling them to modernize their operations and enhance their market strategies. By leveraging AI-first methodologies, the company aims to help life sciences firms optimize their commercialization efforts and stay ahead in an increasingly competitive landscape. To support this initiative, Indegene is expanding its workforce in Europe, bringing in expertise across multiple domains, including consulting, data analytics, customer experience, creative services, and engineering.

“London is a pivotal center for healthcare, technology, and business innovation, making it an attractive market for life sciences companies. By establishing a new center in London, we are poised to strengthen our collaboration with clients, drive innovation, and support their commercialization goals with an AI-first approach,” shared Manish Gupta, Chairman and CEO of Indegene. 

Also Read :- India AI Mission and Gates Foundation to Drive AI Innovation in Healthcare, Agriculture, Education, and Climate Resilience

This expansion follows Indegene’s recent launch of a new entity in Spain, further reinforcing its growing influence in the European life sciences sector. The company already operates in key European markets, including Germany, Ireland, and Switzerland. Indegene has also been actively expanding through acquisitions, such as its 2023 purchase of Trilogy Writing & Consulting GmbH, a global medical writing services provider with teams in the UK, Germany, and the US. Additionally, its 2019 acquisition of DT Associates (now DT Consulting) enhanced its consulting capabilities for healthcare and life sciences clients in the UK.

With a strong reputation for delivering commercialization solutions, Indegene is a trusted partner to the world’s leading biopharmaceutical and medical technology companies. Its integrated approach, combining deep industry expertise with innovative technology, enables life sciences organizations to bring their products to market efficiently and drive sustained impact throughout the product lifecycle.

Indegene Limited is dedicated to empowering healthcare organizations to be future-ready. The company provides a wide range of solutions aimed at enhancing patient and physician engagement through personalized, scalable, and omnichannel strategies. With its continued expansion and investment in key global markets, Indegene is reinforcing its position as a leader in the digital transformation of life sciences commercialization.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!